A citation-based method for searching scientific literature

Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann, Fakhera Ikram, Rene Schmidt, Sandra Ackermann, Anne Engesser, Yvonne Kahlert, Wenzel Vogel, Janine Altmüller, Peter Nürnberg, Jean Thierry-Mieg, Danielle Thierry-Mieg, Aruljothi Mariappan, Stefanie Heynck, Erika Mariotti, Kai-Oliver Henrich, Christian Gloeckner, Graziella Bosco, Ivo Leuschner, Michal R Schweiger, Larissa Savelyeva, Simon C Watkins, Chunxuan Shao, Emma Bell, Thomas Höfer, Viktor Achter, Ulrich Lang, Jessica Theissen, Ruth Volland, Maral Saadati, Angelika Eggert, Bram de Wilde, Frank Berthold, Zhiyu Peng, Chen Zhao, Leming Shi, Monika Ortmann, Reinhard Büttner, Sven Perner, Barbara Hero, Alexander Schramm, Johannes H Schulte, Carl Herrmann, Roderick J O'Sullivan, Frank Westermann, Roman K Thomas, Matthias Fischer. Nature 2015
Times Cited: 320







List of co-cited articles
1171 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
218
47

The genetic landscape of high-risk neuroblastoma.
Trevor J Pugh, Olena Morozova, Edward F Attiyeh, Shahab Asgharzadeh, Jun S Wei, Daniel Auclair, Scott L Carter, Kristian Cibulskis, Megan Hanna, Adam Kiezun,[...]. Nat Genet 2013
680
34

A mechanistic classification of clinical phenotypes in neuroblastoma.
Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke,[...]. Science 2018
115
34

Neuroblastoma.
Katherine K Matthay, John M Maris, Gudrun Schleiermacher, Akira Nakagawara, Crystal L Mackall, Lisa Diller, William A Weiss. Nat Rev Dis Primers 2016
503
26

Recent advances in neuroblastoma.
John M Maris. N Engl J Med 2010
26

Identification of ALK as a major familial neuroblastoma predisposition gene.
Yaël P Mossé, Marci Laudenslager, Luca Longo, Kristina A Cole, Andrew Wood, Edward F Attiyeh, Michael J Laquaglia, Rachel Sennett, Jill E Lynch, Patrizia Perri,[...]. Nature 2008
866
26

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
22

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
Nai-Kong V Cheung, Jinghui Zhang, Charles Lu, Matthew Parker, Armita Bahrami, Satish K Tickoo, Adriana Heguy, Alberto S Pappo, Sara Federico, James Dalton,[...]. JAMA 2012
265
22

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
265
20

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.
Jan J Molenaar, Jan Koster, Danny A Zwijnenburg, Peter van Sluis, Linda J Valentijn, Ida van der Ploeg, Mohamed Hamdi, Johan van Nes, Bart A Westerman, Jennemiek van Arkel,[...]. Nature 2012
592
19

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.
Thomas F Eleveld, Derek A Oldridge, Virginie Bernard, Jan Koster, Léo Colmet Daage, Sharon J Diskin, Linda Schild, Nadia Bessoltane Bentahar, Angela Bellini, Mathieu Chicard,[...]. Nat Genet 2015
299
18

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
18

Neuroblastoma.
John M Maris, Michael D Hogarty, Rochelle Bagatell, Susan L Cohn. Lancet 2007
18

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
Susan L Cohn, Andrew D J Pearson, Wendy B London, Tom Monclair, Peter F Ambros, Garrett M Brodeur, Andreas Faldum, Barbara Hero, Tomoko Iehara, David Machin,[...]. J Clin Oncol 2009
984
18

Neuroblastoma is composed of two super-enhancer-associated differentiation states.
Tim van Groningen, Jan Koster, Linda J Valentijn, Danny A Zwijnenburg, Nurdan Akogul, Nancy E Hasselt, Marloes Broekmans, Franciska Haneveld, Natalia E Nowakowska, Johannes Bras,[...]. Nat Genet 2017
165
16

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Isabelle Janoueix-Lerosey, Delphine Lequin, Laurence Brugières, Agnès Ribeiro, Loïc de Pontual, Valérie Combaret, Virginie Raynal, Alain Puisieux, Gudrun Schleiermacher, Gaëlle Pierron,[...]. Nature 2008
607
15

Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.
Valentina Boeva, Caroline Louis-Brennetot, Agathe Peltier, Simon Durand, Cécile Pierre-Eugène, Virginie Raynal, Heather C Etchevers, Sophie Thomas, Alban Lermine, Estelle Daudigeos-Dubus,[...]. Nat Genet 2017
163
15

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, Katherine K Matthay, Wendy B London, Peter F Ambros, Akira Nakagawara, Frank Berthold, Gudrun Schleiermacher, Julie R Park,[...]. J Clin Oncol 2015
394
15

MYCN amplification and ATRX mutations are incompatible in neuroblastoma.
Maged Zeineldin, Sara Federico, Xiang Chen, Yiping Fan, Beisi Xu, Elizabeth Stewart, Xin Zhou, Jongrye Jeon, Lyra Griffiths, Rosa Nguyen,[...]. Nat Commun 2020
35
42

Overall genomic pattern is a predictor of outcome in neuroblastoma.
Isabelle Janoueix-Lerosey, Gudrun Schleiermacher, Evi Michels, Véronique Mosseri, Agnès Ribeiro, Delphine Lequin, Joëlle Vermeulen, Jérôme Couturier, Michel Peuchmaur, Alexander Valent,[...]. J Clin Oncol 2009
218
14

Mutational dynamics between primary and relapse neuroblastomas.
Alexander Schramm, Johannes Köster, Yassen Assenov, Kristina Althoff, Martin Peifer, Ellen Mahlow, Andrea Odersky, Daniela Beisser, Corinna Ernst, Anton G Henssen,[...]. Nat Genet 2015
171
13

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
676
13

Activating mutations in ALK provide a therapeutic target in neuroblastoma.
Rani E George, Takaomi Sanda, Megan Hanna, Stefan Fröhling, William Luther, Jianming Zhang, Yebin Ahn, Wenjun Zhou, Wendy B London, Patrick McGrady,[...]. Nature 2008
609
13

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
915
12

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.
Samuel W Brady, Yanling Liu, Xiaotu Ma, Alexander M Gout, Kohei Hagiwara, Xin Zhou, Jian Wang, Michael Macias, Xiaolong Chen, John Easton,[...]. Nat Commun 2020
33
36

Chromosome 1p and 11q deletions and outcome in neuroblastoma.
Edward F Attiyeh, Wendy B London, Yael P Mossé, Qun Wang, Cynthia Winter, Deepa Khazi, Patrick W McGrady, Robert C Seeger, A Thomas Look, Hiroyuki Shimada,[...]. N Engl J Med 2005
370
11

Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
A Zhang, C Zheng, C Lindvall, M Hou, J Ekedahl, R Lewensohn, Z Yan, X Yang, M Henriksson, E Blennow,[...]. Cancer Res 2000
122
10

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
10

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
328
10

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Mark Sausen, Rebecca J Leary, Siân Jones, Jian Wu, C Patrick Reynolds, Xueyuan Liu, Amanda Blackford, Giovanni Parmigiani, Luis A Diaz, Nickolas Papadopoulos,[...]. Nat Genet 2013
286
10

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt, Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari,[...]. J Natl Cancer Inst 2018
39
25

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, Wendy B London, Susan G Kreissman, Helen X Chen, Malcolm Smith, Barry Anderson, Judith G Villablanca, Katherine K Matthay,[...]. N Engl J Med 2010
10

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
Tom Monclair, Garrett M Brodeur, Peter F Ambros, Hervé J Brisse, Giovanni Cecchetto, Keith Holmes, Michio Kaneko, Wendy B London, Katherine K Matthay, Jed G Nuchtern,[...]. J Clin Oncol 2009
477
10

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
G M Brodeur, R C Seeger, M Schwab, H E Varmus, J M Bishop. Science 1984
10

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, Shawn J Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle,[...]. Cancer Res 2020
29
34

Oncogenic mutations of ALK kinase in neuroblastoma.
Yuyan Chen, Junko Takita, Young Lim Choi, Motohiro Kato, Miki Ohira, Masashi Sanada, Lili Wang, Manabu Soda, Akira Kikuchi, Takashi Igarashi,[...]. Nature 2008
629
10

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
P F Ambros, I M Ambros, G M Brodeur, M Haber, J Khan, A Nakagawara, G Schleiermacher, F Speleman, R Spitz, W B London,[...]. Br J Cancer 2009
215
9

Targeting MYCN in neuroblastoma by BET bromodomain inhibition.
Alexandre Puissant, Stacey M Frumm, Gabriela Alexe, Christopher F Bassil, Jun Qi, Yvan H Chanthery, Erin A Nekritz, Rhamy Zeid, William Clay Gustafson, Patricia Greninger,[...]. Cancer Discov 2013
416
9


Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
119
9

Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Rachel Litman Flynn, Kelli E Cox, Maya Jeitany, Hiroaki Wakimoto, Alysia R Bryll, Neil J Ganem, Francesca Bersani, Jose R Pineda, Mario L Suvà, Cyril H Benes,[...]. Science 2015
275
9

DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
287
9

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.
Nai-Kong V Cheung, Michael A Dyer. Nat Rev Cancer 2013
483
9

Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
David Clynes, Clare Jelinska, Barbara Xella, Helena Ayyub, Caroline Scott, Matthew Mitson, Stephen Taylor, Douglas R Higgs, Richard J Gibbons. Nat Commun 2015
152
9

MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification.
Mark W Zimmerman, Yu Liu, Shuning He, Adam D Durbin, Brian J Abraham, John Easton, Ying Shao, Beisi Xu, Shizhen Zhu, Xiaoling Zhang,[...]. Cancer Discov 2018
86
10

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
Wenqian Zhang, Ying Yu, Falk Hertwig, Jean Thierry-Mieg, Wenwei Zhang, Danielle Thierry-Mieg, Jian Wang, Cesare Furlanello, Viswanath Devanarayan, Jie Cheng,[...]. Genome Biol 2015
194
9

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
560
8

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
311
8

ALK in Neuroblastoma: Biological and Therapeutic Implications.
Ricky M Trigg, Suzanne D Turner. Cancers (Basel) 2018
59
13

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
246
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.